Baricitinib (INCB28050, LY3009104)

Post Date:
Apr 03,2015
Expiry Date:
Apr 02,2016
Detailed Description:
Cas No. :1187594-09-7 Quantity: 50g
Specs:98% purity
Payment Method: T/T, Western Union
Baricitinib is an orally administered selective JAK1 and JAK2 inhibitor that is JAK3-sparing. Currently, baricitinib is in Phase II development as a treatment for rheumatoid arthritis and psoriasis.
CAS Registry Number:
1187594-09-7
Synonyms:
;2-(3-(4-(7H-Pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile;1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile;LY3009104;INCB028050;
Molecular Formula:
C₁₆H₁₇N₇O₂S
Molecular Weight:
371.41668
Molecular Structure:

Offter to Sell